Putting Alzheimer’s on early notice

Jul 16, 2010
Putting Alzheimer’s on early notice
In vivo imaging of amyloid-beta plaques and brain atrophy of a healthy elderly person (left) compared to an Alzheimer's disease patient (right). (CSIRO)

Australian scientists have presented key findings at an international Alzheimer's disease conference this week. Their major focus is on early detection and discovering why the disease progresses.

The International Conference on in Hawaii heard that scientists from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) have identified advances in imaging and blood screening that will contribute to the earlier detection of Alzheimer’s.

About 250,000 Australians currently have Alzheimer’s disease, but numbers are anticipated to rise to 1.3 million in the next 40 years if there were not significant breakthroughs in prevention and treatment of the disease.

The national collaborative approach taken by AIBL scientists was initiated by CSIRO’s Preventative Health National Research Flagship on Alzheimer’s prevention research and has resulted in 22 research papers being accepted and presented at the conference.

The director of CSIRO’s Preventative Health Flagship, Professor Richard Head, said many of the major contributions presented at the conference were only made possible through the national collaboration of scientists from a wide range of disciplines across Australia.

"This collaboration has provided critical expertise and capability at a size necessary to enable us to understand early identification of the disease and the contributing factors to its progression," Professor Head said. 

"The advancement in our research would not have been as strong or as rapid were it not for the broad range of expertise brought together by this collaboration."

The level of recognition from the world’s leading forum on research confirms the success of the initiative, he said.

Professor Head said the AIBL research has combined advanced neuroimaging, cognitive performance studies, blood screening and lifestyle studies to start identifying early indicators of the disease.

"The imaging component alone has potentially brought forward the detection of Alzheimer's disease by 18 months," he said.

Explore further: Cerebral palsy may be hereditary

add to favorites email to friend print save as pdf

Related Stories

Advance towards early Alzheimer's diagnosis

Jun 18, 2008

The leader of the team that made the discovery, Professor Christopher Rowe of the Austin Hospital in Melbourne, says early diagnosis and treatment presents medical practitioners with the best opportunity to delay the onset ...

Alzheimer's disease to quadruple worldwide by 2050

Jun 10, 2007

More than 26 million people worldwide were estimated to be living with Alzheimer’s disease in 2006, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers also concluded ...

Advance in bowel cancer test research

Jun 04, 2009

(PhysOrg.com) -- Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Study finds certain drugs cut Alzheimer's

Dec 06, 2006

U.S. scientists say they've identified anti-hypertensive agents that can prevent cognitive decline and amyloid neuropathology in Alzheimer patients.

Recommended for you

Cerebral palsy may be hereditary

4 hours ago

Cerebral palsy is a neurological developmental disorder which follows an injury to the immature brain before, during or after birth. The resulting condition affects the child's ability to move and in some ...

19 new dengue cases in Japan, linked to Tokyo park

10 hours ago

Japan is urging local authorities to be on the lookout for further outbreaks of dengue fever, after confirming another 19 cases that were contracted at a popular local park in downtown Tokyo.

User comments : 0